SCYNEXIS, Inc. (SCYX)

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SCYNEXIS, Inc. (“Scynexis” or “the Company”) (NASDAQ: SCYX). Investors who purchased Scynexis securities prior to March 31, 2023, and continue to hold to the present, are encouraged to obtain additional information… read more

Holley Inc. (HLLY)

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Holley Inc. (“Holley” or “the Company”) (NYSE: HLLY). Investors who purchased Holley securities prior to July 21, 2021, and continue to hold to the present, are encouraged to obtain additional information… read more

Alteryx, Inc. (AYX)

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Alteryx, Inc. (“Alteryx” or “the Company”) (NYSE: AYX). Investors who purchased Alteryx securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Alteryx has violated federal… read more

Gildan Activewear Inc. (GIL)

Gildan Activewear Inc. (GIL) Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Gildan Activewear Inc. (“Gildan” or “the Company”) (NYSE: GIL). Investors who purchased Gildan securities are encouraged to obtain additional information and assist the investigation. The investigation concerns… read more

The Procter & Gamble Company (PG)

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Procter & Gamble Company (“Procter & Gamble” or “the Company”) (NYSE: PG). Investors who purchased Procter & Gamble securities are encouraged to obtain additional information and assist the investigation. The… read more

Blackstone Mortgage Trust, Inc. (BXMT)

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Blackstone Mortgage Trust, Inc. (“Blackstone” or “the Company”) (NYSE: BXMT). Investors who purchased Blackstone securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Blackstone has… read more

Rover Group, Inc. (ROVR)

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Rover Group, Inc. (“Rover” or “the Company”) (NASDAQ: ROVR). Investors who purchased Rover securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether the sale of… read more

NUBURU, Inc. (BURU)

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Tailwind Acquisition Corp.  (“Tailwind”), which merged with NUBURU, Inc. (“NUBURU”) (NYSE: BURU) on February 1, 2023. Investors who purchased Tailwind and continue to hold to the present, are encouraged to obtain… read more

Illumina, Inc. (ILMN)

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Illumina, Inc. (“Illumina” or “the Company”) (NASDAQ: ILMN). Investors who purchased Illumina securities prior to September 21, 2020, and continue to hold to the present, are encouraged to obtain additional information… read more

The Beachbody Company Group, LLC (BODY)

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Forest Road Acquisition Corp. (“Forest Road”), which merged with The Beachbody Company Group, LLC (“Beachbody”) (NYSE: BODY) on June 28, 2021. Such investors who purchased Forest Road and continue to hold Beachbody to the present are encouraged to obtain additional information and assist the investigation…. read more

Expensify, Inc. (EXFY)

Bronstein, Gewirtz & Grossman, LLC a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Expensify, Inc. (“Expensify” or “the Company”) (NASDAQ: EXFY) and certain of its officers. Class Definition: This lawsuit seeks to recover damages against Defendants for… read more

 Sotera Health Company (SHC) 

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sotera Health Company (“Sotera” or the “Company”) (NASDAQ: SHC). Investors who purchased Sotera securities prior to January 2022, and continue to hold to the present, are encouraged to obtain additional information… read more